カテゴリ： Grand View Research, 世界, 医療/バイオ

前臨床CROの世界市場：サービス別（生体分析及びDMPK研究、毒性試験）、最終用途別（バイオ製薬企業、医療機器企業）

◆英語タイトル：Preclinical CRO Market Size, Share & Trends Analysis Report By Services (Bioanalysis & DMPK Studies, Toxicology Testing), By End Use (Biopharmaceutical Companies, Medical Device Companies), And Segment Forecasts, 2020 - 2027
◆商品コード：GV20MY065
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2020年3月30日
◆ページ数：100
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥624,750見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥729,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥939,750見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
本調査レポートでは、前臨床CROの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、サービス別（生体分析及びDMPK研究、毒性試験、その他）分析、最終用途別（バイオ製薬企業、政府および学術機関、医療機器企業）分析、地域別分析、競争分析などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・前臨床CROの世界市場：サービス別（生体分析及びDMPK研究、毒性試験、その他）
・前臨床CROの世界市場：最終用途別（バイオ製薬企業、政府および学術機関、医療機器企業）
・前臨床CROの世界市場：地域別
・競争分析
【レポートの概要】

The global preclinical CRO market size is expected to reach USD 7.8 billion by 2027, registering a CAGR of 8.3% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trend, which is expected to increase the demand for preclinical trials in the future. Whereas rise in number of complex drugs entering clinical trials and increasing R&D expenses are some of the factors responsible for the preclinical Contract Research Organization (CRO) growth. Increasing prices and changes in reimbursement policies are also anticipated to boost the in emerging countries such as India and China.

Increasing number of new entrants in market is anticipated to help the market to grow during the forecast period. Various companies are focusing on research and development of new drugs and therefore are outsourcing these activities to launch efficient CRO services in the market.

Further key findings from the report suggest:

• Toxicology testing held the largest share in the service segment in 2019 due to increasing trend of outsourcing, especially in emerging countries

• Bioanalysis is expected to grow with the highest CAGR of 8.8% over the forecast period

• North America dominates the market with the largest share of 47.5% in 2019 owing to advanced healthcare infrastructure in the region

• The Asia Pacific region is projected to witness the fastest growth during the forecast period owing to government support in development of outsourcing hubs along with availability of skilled practitioners

• Some of the key preclinical CRO market players are Envigo Corporation, MPI research, and Eurofins Scientific.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and end-use scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Preclinical CRO Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Service
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Suring number of drugs in preclinical phases
3.4.1.2. Economies of production and scale
3.4.1.3. Increasing R&D expenditure
3.4.2. Market Restraint Analysis
3.4.2.1. High labor cost
3.4.2.2. Stringent regulatory policies
3.4.3. Industry Challenges
3.4.3.1. Managing the relationships
3.5. Preclinical CRO: Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Preclinical CRO Market : Segment Analysis, by Services, 2016 – 2027 (USD Million)
4.1. Definitions & Scope
4.2. Product market share analysis, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Preclinical CRO Market, by services, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
4.5.1. Bioanalysis and DMPK studies
4.5.2. Toxicology testing
4.5.3. Others
Chapter 5. Preclinical CRO Market : Segment Analysis, By End-use, 2016 – 2027 (USD Million)
5.1. Definitions & Scope
5.2. End-use market share analysis, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Preclinical CRO market, by end-use, 2016 to 2027
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.5.1. Biopharmaceutical companies
5.5.2. Government and academic institutes
5.5.3. Medical device companies
Chapter 6. Preclinical CRO Market : Regional Market Analysis, By Services, 2016 – 2027 (USD Million)
6.1. Definitions & Scope
6.2. Regional Market Share Analysis, 2019 & 2027
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Regional Market Share, 2018
6.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
6.7. North America
6.7.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.7.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.7.3. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.7.4. U.S.
6.7.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.7.4.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.7.5. Canada
6.7.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.7.5.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.8.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.3. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.4. Germany
6.8.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.4.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.5. U.K.
6.8.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.5.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.6. France
6.8.6.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.6.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.7. Italy
6.8.7.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.7.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.8. Spain
6.8.8.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.8.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.9. Netherlands
6.8.9.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.9.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.10. Belgium
6.8.10.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.10.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.11. Switzerland
6.8.11.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.11.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.12. Russia
6.8.12.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.12.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.8.13. Sweden
6.8.13.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.8.13.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.9.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.3. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.4. China
6.9.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.4.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.5. Japan
6.9.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.5.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.6. India
6.9.6.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.6.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.7. Australia
6.9.7.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.7.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.8. South Korea
6.9.8.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.8.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.9. Malaysia
6.9.9.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.9.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.10. Indonesia
6.9.11. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.12. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.13. Singapore
6.9.14. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.15. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.16. Philippines
6.9.17. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.18. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.9.19. Thailand
6.9.20. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.9.21. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.10.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.10.3. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.10.4. Brazil
6.10.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.10.4.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.10.5. Mexico
6.10.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.10.5.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.10.6. Argentina
6.10.6.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.10.6.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.10.7. Colombia
6.10.7.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.10.7.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.10.8. Chile
6.10.8.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.10.8.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.11. Middle East and Africa
6.11.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.11.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.11.3. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.11.4. South Africa
6.11.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.11.4.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.11.5. Saudi Arabia
6.11.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.11.5.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.11.6. UAE
6.11.6.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.11.6.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.11.7. Israel
6.11.7.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.11.7.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
6.11.8. Egypt
6.11.8.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Million)
6.11.8.2. Market estimates and forecast, by End-use, 2016 – 2027 (USD Million)
Chapter 7. Preclinical CRO Market – Competitive Analysis
7.1. Key companies profiled
7.1.1. Envigo Corporation
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. MPI research
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Eurofins Scientific
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. PRA Health Sciences, Inc
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Wuxi AppTec
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Medpace, Inc.
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Pharmaceutical Product Development (PPD), LLC
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. PARAXEL International Corporation
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. ICON Plc.
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Laboratory Corporation of America, Inc.
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives

List of Tables

TABLE 1 Facial Recognition Market Outlook
TABLE 2 Global Facial recognition market, 2016 - 2027 (USD Million)
TABLE 3 Global Facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 4 Global Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 5 Global Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 6 Global Facial recognition market by end-use, (USD Million), 2016 - 2027
TABLE 7 Facial recognition - Key market driver impact
TABLE 8 Facial recognition - Key market restraint impact
TABLE 9 List of key market players
TABLE 10 Global 2D facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 11 Global 3D facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 12 Global facial analytics facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 13 Global emotion recognition facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 14 Global attendance tracking and monitoring facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 15 Global access control facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 16 Global security & surveillance facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 17 Global others facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 18 Global retail & e-commerce facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 19 Global media & entertainment facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 20 Global BFSI facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 21 Global automobile & transportation facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 22 Global telecom & IT facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 23 Global government facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 24 Global healthcare facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 25 Global others facial recognition market by region, 2016 - 2027 (USD Million)
TABLE 26 North America Facial recognition market, 2016 - 2027 (USD Million)
TABLE 27 North America Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 28 North America Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 29 North America Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 30 U.S. Facial recognition market, 2016 - 2027 (USD Million)
TABLE 31 U.S. Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 32 U.S. Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 33 U.S. Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 34 Canada Facial recognition market, 2016 - 2027 (USD Million)
TABLE 35 Canada Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 36 Canada Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 37 Canada Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 38 Mexico Facial recognition market, 2016 - 2027 (USD Million)
TABLE 39 Mexico Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 40 Mexico Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 41 Mexico Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 42 Europe Facial recognition market, 2016 - 2027 (USD Million)
TABLE 43 Europe Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 44 Europe Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 45 Europe Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 46 Germany. Facial recognition market, 2016 - 2027 (USD Million)
TABLE 47 Germany Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 48 Germany Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 49 Germany Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 50 U.K. Facial recognition market, 2016 - 2027 (USD Million)
TABLE 51 U.K. Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 52 U.K. Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 53 U.K. Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 54 France Facial recognition market, 2016 - 2027 (USD Million)
TABLE 55 France Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 56 France Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 57 France Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 58 Asia Pacific Facial recognition market, 2016 - 2027 (USD Million)
TABLE 59 Asia Pacific Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 60 Asia Pacific Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 61 Asia Pacific Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 62 China Facial recognition market, 2016 - 2027 (USD Million)
TABLE 63 China Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 64 China Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 65 China Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 66 Japan Facial recognition market, 2016 - 2027 (USD Million)
TABLE 67 Japan Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 68 Japan Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 69 Japan Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 70 India Facial recognition market, 2016 - 2027 (USD Million)
TABLE 71 India Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 72 India Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 73 India Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 74 South America Facial recognition market, 2016 - 2027 (USD Million)
TABLE 75 South America Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 76 South America Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 77 South America Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 78 Brazil Facial recognition market, 2016 - 2027 (USD Million)
TABLE 79 Brazil Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 80 Brazil Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 81 Brazil Facial recognition market by end-use, 2016 - 2027 (USD Million)
TABLE 82 MEA Facial recognition market, 2016 - 2027 (USD Million)
TABLE 83 MEA Facial recognition market by technology, 2016 - 2027 (USD Million)
TABLE 84 MEA Facial recognition market by application, 2016 - 2027 (USD Million)
TABLE 85 MEA Facial recognition market by end-use, 2016 - 2027 (USD Million)

List of Figures

FIG. 1 Research process
FIG. 2 Market Formulation
FIG. 3 Market segmentation & scope
FIG. 4 Global facial recognition market 2016 - 2027 (USD Million)
FIG. 5 Facial recognition market size and growth prospects (USD Million)
FIG. 6 Facial recognition - Value chain analysis
FIG. 7 Market dynamics
FIG. 8 Regional outlook, 2019 & 2027

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[前臨床CROの世界市場：サービス別（生体分析及びDMPK研究、毒性試験）、最終用途別（バイオ製薬企業、医療機器企業）]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 薬事申請（RA）アウトソーシングの世界市場：サービス別（法的代理、規制コンサルティング）、最終用途別（医療機器企業、製薬企業）、地域別
    GV20MY069 / Grand View Research / 2020年3月3日 / 本調査レポートでは、薬事申請アウトソーシング（RA）の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、サービス別（規制コンサルティング、法的代理、規制文書および出版、製品登録および臨床試験申請、その他）分析、最終用途別（医療機器企業、製薬企業、バイオテクノロジー企業）分析、地域分析、競争分析などの構成でお届けいたします。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・薬事申請（RA）アウトソーシングの世界市場：サービス別（規制コンサルティング、法的代理、規制文書および出版、製品登録および臨床試験申請、その他） ・薬事申請（RA）アウトソーシングの世界市場：最終用途別（医療機器企業、製薬企業、バイオテクノロジー企業） ・薬事申請（RA）アウトソーシングの世界市場：地域別 ・競争分析...The global regulatory affairs outsourcing market size is expected to reach USD 15.6 billion by 2027, expanding at a CAGR of 11.9%, according to a new report by Grand View Research, Inc. The entry of life sciences companies in global markets and the evolution of new areas such as orphan drugs, biosimilars, and personalized medicine are propelling market growth. A significant increase in the fixed costs of in-house resources for healthcare regulatory affairs and operation activities like training, technology, specialized knowledge, and facilities are driving life science firms to outsource these functions. Also, the rising number of clinical trials is...
  2. CRISPR＆Cas遺伝子の世界市場2020-2027：製品・サービス別（ベクターベースCas、DNA-freeCas、細胞株エンジニアリング）、用途別、最終用途別
    GV20JN256 / Grand View Research / 2020年5月 / 本調査レポートでは、CRISPR＆Cas遺伝子の世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、産業動向、競争状況、製品・サービス別（ベクターベースCas、DNA-freeCas、細胞株エンジニアリング）分析、用途別分析、最終用途別分析、地域別分析、企業情報など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・産業動向 ・競争状況 ・CRISPR＆Cas遺伝子の世界市場規模：製品・サービス別（ベクターベースCas、DNA-freeCas、細胞株エンジニアリング） ・CRISPR＆Cas遺伝子の世界市場規模：用途別 ・CRISPR＆Cas遺伝子の世界市場規模：最終用途別 ・CRISPR＆Cas遺伝子の世界市場規模：地域別...CRISPR & Cas Genes Market Growth & Trends The global clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes market size is expected to reach USD 4.88 billion by 2027, expanding at a CAGR of 16.6% from 2020 to 2027, according to a new report by Grand View Research, Inc. Rise in the adoption of CRISPR technology in epigenetics, therapeutics, human germline editing, plant genome editing, and other fields of biotechnology is expected to drive the market. Presence of a large number of service providers that provide knockout, knock-in, gene repression, gene activation, and other cell line engineering...
  3. コーポレートウェルネスの世界市場：サービス別（健康リスク評価、フィットネス、禁煙）、最終用途別、カテゴリ別、種類別、デリバリーモデル別、地域別
    GV20MY043 / Grand View Research / 2020年2月24日 / 本調査レポートでは、コーポレートウェルネスの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、サービス別（健康リスク評価、フィットネス、禁煙、健康診断、栄養及び体重管理、ストレス管理、その他）分析、最終用途別（小規模組織、中規模組織、大規模組織）分析、カテゴリ別（フィットネス＆栄養コンサルタント、心理療法士、組織/雇用主）分析、種類別（サービス、テクノロジー）分析、デリバリーモデル別（オンサイト、オフサイト）分析、地域別分析、競争分析などの構成でお届けいたします。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・コーポレートウェルネスの世界市場：サービス別（健康リスク評価、フィットネス、禁煙、健康診断、栄養及び体重管理、ストレス管理、その他） ・コーポレートウェルネスの世界市場：最終用途別（小規模組織、中規模組織、大規模組織） ・コーポレートウェルネスの世界市場：カテゴリ別（フィットネス＆栄養コンサルタント、心理療法士、組織/雇用主） ・コーポレートウェルネスの世界市場：種類別（サービス、テクノロジー） ・コーポレートウェルネスの世界市場：デリバリーモデル別（オンサイト、オフサイト） ・コーポレートウェルネスの世界市場：地域別...The global corporate wellness market size is expected to reach USD 97.4 billion by 2027, expanding at a CAGR of 6.9%, according to a new report by Grand View Research, Inc. Rising lifestyle related disorders lead to rise in financial burden on the employers due to associated insurance costs. The corporate wellness initiatives target specific health risk factors including stress, obesity, smoking, poor eating, and lack of exercise to improve employee productivity. Organizations have initiated the implementation of wellness programs to improve business profits by reducing employee healthcare related costs. According to a study conducted by Harvard economists, absenteeism costs...
  4. クリーンルーム技術の世界市場：製品タイプ別（機器、消耗品）、最終用途別（医薬品、医療機器、バイオテクノロジー）、地域別
    GV20MY038 / Grand View Research / 2020年3月16日 / 本調査レポートでは、クリーンルーム技術の世界市場について調査・分析し、調査手法、エグゼクティブサマリー、産業概要、製品タイプ別（機器、消耗品）分析、最終用途別（医薬品、医療機器、バイオテクノロジー）分析、地域別分析、競争状況などの構成でお届けいたします。 ・調査手法 ・エグゼクティブサマリー ・産業概要 ・クリーンルーム技術の世界市場：製品タイプ別（機器、消耗品） ・クリーンルーム技術の世界市場：最終用途別（医薬品、医療機器、バイオテクノロジー） ・クリーンルーム技術の世界市場：地域別 ・競争状況...The global cleanroom technology market size is expected to reach USD 5.3 billion by 2027, expanding at a CAGR of 3.8%, according to a new report by Grand View Research, Inc. Technological advancement in cleanroom equipment, increasing need for cleanroom technology to develop quality products, and initiatives taken by private and public organizations to create awareness are key factors driving market growth. Manufacturing companies in various industries are dependent on cleanroom technology in order to comply with the stringent regulatory standards. Moreover, there has been an increase in need for standardizing cleanroom standards due to presence of a wide range...
  5. 皮膚リサーフェシングの世界市場2020-2027：タイプ別（アブレイティブ、非アブレイティブ）、製品別、最終用途別、用途別、地域別
    GV20JN095 / Grand View Research / 2020年5月 / 本調査レポートでは、皮膚リサーフェシングの世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、タイプ別（アブレイティブ、非アブレイティブ）分析、製品別分析、最終用途別分析、用途別分析、地域別分析、競争分析など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・皮膚リサーフェシングの世界市場規模：タイプ別（アブレイティブ、非アブレイティブ） ・皮膚リサーフェシングの世界市場規模：製品別 ・皮膚リサーフェシングの世界市場規模：最終用途別 ・皮膚リサーフェシングの世界市場規模：用途別 ・皮膚リサーフェシングの世界市場規模：地域別 ・競争分析...Skin Resurfacing Market Growth & Trends The global skin resurfacing market size is expected to reach a value of USD 378.4 million by 2027, expanding at a CAGR of 7.2%, according to a new report by Grand View Research, Inc. High incidence of medical conditions such as acne in adolescents and a rapidly aging population is anticipated to drive the market. High influence of social media and rise in usage of smartphones and photo editing applications is anticipated to fuel a desire for flawless and glowing face, thereby increasing the demand for the rejuvenation services. For instance, Facebook, YouTube, Instagram,...
  6. 歯科生体材料の世界市場2020-2027：タイプ別（金属、セラミック、ポリマー）、用途別、最終用途別、地域別
    GV20JN096 / Grand View Research / 2020年5月 / 本調査レポートでは、歯科生体材料の世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、タイプ別（金属、セラミック、ポリマー）分析、用途別分析、最終用途別分析、地域別分析、競争分析など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・歯科生体材料の世界市場規模：タイプ別（金属、セラミック、ポリマー） ・歯科生体材料の世界市場規模：用途別 ・歯科生体材料の世界市場規模：最終用途別 ・歯科生体材料の世界市場規模：地域別 ・競争分析...Dental Biomaterials Market Growth & Trends The global dental biomaterials market size is expected to reach USD 12.3 billion by 2027, expanding at a CAGR of 6.2%, according to a new report by Grand View Research, Inc. Rising prevalence of tooth disorder is one of the major factors contributing to market growth. Dental biomaterials include biocompatible synthetic materials and natural tissues to restore tooth decay, damage, and fractures problems. As the geriatric population worldwide affected by tooth decay is huge despite significant advances in tooth restoration and caries prevention, the rising incidence of tooth disorder continues to pose a considerable...
  7. 使い捨て内視鏡の世界市場：用途別（気管支鏡検査、直腸鏡検査、関節鏡検査）、最終用途別（病院、診断センター、クリニック）
    GV20MY048 / Grand View Research / 2020年3月4日 / 本調査レポートでは、使い捨て内視鏡の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、用途別（気管支鏡検査、泌尿器内視鏡検査、関節鏡検査、胃腸内視鏡検査、ENT内視鏡検査、その他）分析、最終用途別（病院、診断センター、その他）分析、地域別分析、競争状況などの構成でお届けいたします。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・使い捨て内視鏡の世界市場：用途別（気管支鏡検査、泌尿器内視鏡検査、関節鏡検査、胃腸内視鏡検査、ENT内視鏡検査、その他） ・使い捨て内視鏡の世界市場：最終用途別（病院、診断センター、その他） ・使い捨て内視鏡の世界市場：地域別 ・競争状況...The global disposable endoscopes market size is expected to reach USD 4.45 billion by 2027 and is expected to expand at a CAGR of 19.8% over the forecast period, according to a new report published by Grand View Research, Inc. Increasing incidence of Hospital-acquired Infections (HAI) is one of the pivotal factors attributed to the growth. Furthermore, high capital cost associated with cleaning, maintenance, reprocessing and storage cabinets and equipment is also of the factors compelling healthcare establishments to opt of disposable endoscopes. Increasing prevalence of target diseases including cancer, ENT, Neurological, GI disorders and others is further boosting the...
  8. 生物学的安全キャビネットの世界市場2020-2027：製品タイプ別（クラスI、II、III）、最終用途別
    GV20JN094 / Grand View Research / 2020年5月 / 本調査レポートでは、生物学的安全キャビネットの世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、製品タイプ別（クラスI、II、III）分析、最終用途別分析、地域別分析、競争分析など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・生物学的安全キャビネットの世界市場規模：製品タイプ別（クラスI、II、III） ・生物学的安全キャビネットの世界市場規模：最終用途別 ・生物学的安全キャビネットの世界市場規模：地域別 ・競争分析...Biological Safety Cabinets Market Growth & Trends The global biological safety cabinets market size is expected to reach USD 282.1 million by 2027, registering a CAGR of 7.5%, according to a new report by Grand View Research, Inc. Technological advancements due to a rise in laboratory procedures performed that play a crucial role in the safety of personnel, product, and environment, have propelled the market growth. The introduction of smart biosafety cabinets, such as PureLogic+ manufactured by Labconco Inc., with new features and adjustable accessories is playing a crucial role in the growth of the market. To improve the safety,...
  9. ヘルスケア受託製造開発機関（CDMO）の世界市場2020-2027：サービス別（契約開発、受託製造）、地域別
    GV20JN031 / Grand View Research / 2020年4月 / 本調査レポートでは、ヘルスケア受託製造開発機関（CDMO）の世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、サービス別（契約開発、受託製造）分析、地域別分析、競争分析など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・ヘルスケア受託製造開発機関（CDMO）の世界市場規模：サービス別（契約開発、受託製造） ・ヘルスケア受託製造開発機関（CDMO）の世界市場規模：地域別 ・競争分析...The global healthcare contract development and manufacturing organization market size is expected to reach USD 352.3 billion by 2027, registering a CAGR of 8.1% over the forecast period, according to a new report by Grand View Research, Inc. Increasing outsourcing of R&D is one of the major factors contributing to the market growth. Healthcare contract development and manufacturing organization (CDMO) provides outsourcing services to various pharmaceutical industries on contract basis. Increase in the outsourcing by pharmaceutical companies, growing pharmaceutical industry, and support of CDMOs in reducing the operational and capital expenses are some of the major factors anticipated to propel...
  10. マルチパラメータ患者モニタリングシステムの世界市場2020-2027：デバイスタイプ別（固定型、携帯型）、視力レベル別、年齢層別、最終用途別、地域別
    GV20JN092 / Grand View Research / 2020年5月 / 本調査レポートでは、マルチパラメータ患者モニタリングシステムの世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、デバイスタイプ別（固定型、携帯型）分析、視力レベル別分析、年齢層別分析、最終用途別分析、地域別分析、競争分析など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・マルチパラメータ患者モニタリングシステムの世界市場規模：デバイスタイプ別（固定型、携帯型） ・マルチパラメータ患者モニタリングシステムの世界市場規模：視力レベル別 ・マルチパラメータ患者モニタリングシステムの世界市場規模：年齢層別 ・マルチパラメータ患者モニタリングシステムの世界市場規模：最終用途別 ・マルチパラメータ患者モニタリングシステムの世界市場規模：地域別 ・競争分析...Multiparameter Patient Monitoring Systems Market Growth & Trends The global multiparameter patient monitoring systems market size is expected to reach USD 15.4 billion by 2027 registering a CAGR of 5.5%, according to a new report by Grand View Research, Inc. Rising health concerns and resultant need to constantly monitor the health parameters of patients, before and after surgery is creating demand for multiparameter patient monitoring systems. The market growth is also supported by the increasing need for hospital transport, such as intrahospital or out-of-the-hospital transport. For special examination and therapy, hospitals require intrahospital transport, which calls for more continuous monitoring...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆